Introduction
There are two major glomerular diseases in which a Major advances in the basic sciences of immunology, massive increase in glomerular permeability occurs in cell biology, and molecular biology over the past the absence initially of any morphological alteradecade have lead to important new insights into the tions in glomerular structure. These are minimal pathogenesis of kidney diseases. This review will focus change/focal sclerosis and idiopathic membranous on current understanding of immunological glomerular nephropathy. Both of these lesions can be closely diseases emphasizing insights derived from recent stud-simulated in animal models in which the principal site ies, particularly as they relate to clinical glomerular of immune attack is at the level of the glomerular diseases. In reviewing this area, I will focus primarily epithelial cell (GEC ). on the mechanisms which cause acute rather than Glomerular injury due to non-complement fixing antibodchronic progressive disease and particularly on pro-ies. In minimal change/focal sclerosis there is now teinuria as a marker of glomerular injury. I will further increasing evidence that nephrotic syndrome results subdivide mechanisms of glomerular tissue injury into from glomerular effects of circulating permeability those that are associated with inflammatory changes factors probably derived from immunocompetent cells. by light microscopy and those that are non-Thus, hybridomas of T cells from patients with active inflammatory in nature. The major pathways of injury minimal change disease secrete a factor that can transas they are currently understood are depicted schemat-fer a similar lesion to the rat [6 ] , and patients with ically in Figure 1 . More detailed reviews of this subject active focal sclerosis evidenced by the recurrence of have been published elsewhere [1] [2] [3] .
disease in renal transplants usually exhibit a serum factor which can induce an increase in albumin permeability in normal rats and in the isolated normal
Mediation of glomerular injury
glomerulus [7, 8] . There is now evidence from several sources that the circulating permeability factor in some Although lesions with similarities to those in man can patients may be IL-8 or an IL-8-like molecule [9, 10] . be induced with a variety of exogenous antigens of While these circulating permeability factors are not varying sizes and charges [Reviewed in 3] , it is now immunoglobulins, lesions which closely simulate the becoming increasingly apparent that most immunologically mediated glomerular diseases in man are autoimmune in nature [4] . Thus, many of these lesions result from the glomerular binding of antibodies directed specifically against normal glomerular structures at different locations (although local immune complex formation involving exogenous antigens planted at these same sites appears to activate similar mechanisms). There are now six well studied pathways by which immune deposit formation at various sites in the glomerulus can induce both structural and functional evidence of glomerular disease. These six pathways are reviewed below and are depicted schematically in Figure 1 . isms by which immune deposits mediate glomerular injury.
structural and functional features of minimal complex with extrusion into the urinary space without causing apparent cell injury [22] . change/focal sclerosis can be induced in animals by a variety of antibodies that have in common the ability
The mechanism by which C5b-9 causes proteinuria is still unclear. Like the permeability factors discussed to bind to the membrane of the GEC without fixing complement. These antibodies, which include some above, the effect of C5b-9 occurs without inducing cell lysis. In vitro studies document that C5b-9 in sub-lytic anti-glomerular antibodies, anti-fx1A f(ab∞) 2 , monoclonal antibodies K9/9 and 5-1-6 [10] [11] [12] , all induce a quantities acts as a potent stimulus to production of several toxic metabolites by glomerular cells including dramatic change in the shape of the GEC accompanied by areas of detachment of GEC from underlying oxidants, proteases, prostaglandins and various cytokines and growth factors [23] . The currently available glomerular basement membrane (GBM ). It seems likely that better understanding of how these antibodies evidence suggests that oxidant production by the GEC in response to sublytic C5b-9 attack may be responsible cause glomerular injury will also clarify how nonimmunoglobulin permeability factors damage the for the alteration in basement membrane permeability that leads to nephrotic syndrome in MN [24, 25] . glomerulus as well. These models provide the opportunity to conduct such further studies. Possible mech-However, a marked upregulation of GEC production of the proteinase MMP9 has also been documented in anisms include stimulation of release by GEC of materials which directly damage underlying GBM such experimental MN [26 ] . The relative importance of oxidants versus proteases in mediating capillary wall as oxidants or proteases, or interference with molecules such as integrins which regulate cell-matrix interaction injury in MN remains to be determined.
In addition to the role of GEC-derived oxidants and leading to cell detachment from GBM, or both. Much has been learned recently regarding the molecular proteases in causing an increase in protein permeability in membranous nephropathy, it has recently been mechanisms which regulate the adherence of glomerular cells to GBM, and disorders of these processes shown that there is also a complement-dependent increase in GEC production of TGFb isoforms II and may be particularly important in the pathogenesis of non-inflammatory types of injury in diseases such as III as well as TGFb receptors which likely mediate the overproduction of extracellular matrix components minimal change disease [13] . Glomerular injury induced by complement fixing antibod-that result in the formation of subepithelial spikes and basement membrane thickening so characteristic of ies and C5b-9. (a) Anti-GEC antibodies. Like minimal change/focal sclerosis, the initial glomerular lesion in this disease [27] .
(b) Anti-mesangial cell antibody. Although C5b-9 membranous nephropathy (MN ) is also a totally noninflammatory one. However, in MN there are extensive attack has been well established as a mechanism of disease involving the GEC in membranous nephrosubepithelial deposits of antibody and complement components including C3 and C5b-9. While the nature pathy, its relevance to mesangial diseases such as IgA nephropathy is less clear. However, complement fixing of the deposited antibody in human MN has not yet been established, many other aspects of the immunopa-IgG or IgA autoantibodies to mesangial cells, or other mesangial components, have been reported in IgA thogenesis of MN are now understood based on studies of the Heymann nephritis models in rats which closely nephropathy [28, 29] , IgA can activate complement by the alternative pathway [30] and C5b-9 deposition is simulate the human lesion.
In Heymann nephritis, subepithelial immune prominent in mesangial immune complex diseases [31] .
In vitro, C5b-9 is a potent stimulus to mesangial cell deposits result from antibody binding to antigens on the surface of the GEC, the best characterized of which production of several mediators including oxidants, proteases, prostaglandins, leukotrienes, and matrix is gp330 localized in the clathrin-coated pits [14] . Antibody binding to the GEC membrane induces components [23] . The anti-thymocyte serum (ATS) model of mesangioproliferative glomerulonephritis in complement activation, probably via the alternative complement pathway. Because the deposits form only the rat exhibits many of the features of immune complex induced mesangioproliferative glomeruloon the outer, or subepithelial surface of the glomerular capillary wall, complement and immunoglobulin nephritis in man such as IgA nephropathy. Studies utilizing cobra venom factor to produce generalized derived chemotactic and immune adherence proteins are not interactive with circulating cells probably complement depletion have shown that most of the morphological and functional changes which occur in accounting for the non-inflammatory nature of the lesion. Proteinuria, however, is very complement-the ATS model are complement-dependent [32] . To test the role of C5b-9 in immune diseases of the dependent and appears to be mediated primarily by the C5b-9 membrane attack complex of complement mesangium, ATS was induced in C-6 deficient and control PVG rats. There was a marked reduction in [reviewed in 15-17]. Thus, nephritogenic quantities of antibody fail to cause proteinuria in the intact animal glomerular mesangiolysis, platelet infiltration, mesangial cell proliferation, macrophage infiltration and [18], isolated perfused kidney [19] and isolated glomerulus [20] if manoeuvers to prevent C5b-9 formation matrix expansion in C-6 deficient compared to control animals [33] . Whether this involvement of C5b-9 in are introduced. In some models a complementindependent effect of anti-GEC antibody has also been mesangial disease represents sublytic effects of C5b-9 on the mesangial cell leading to local generation of described [21] . In vivo, C5b-9 insertion into GEC membranes causes transcellular transport of the C5b-9 inflammatory mediators as apparently occurs with the GEC, a mitogenic effect of the C5b-9 leading to nephropathy, rapidly progressive GN, lupus nephritis and membranoproliferative GN. A plethora of recent mesangial cell proliferation with release of mediators or a role of C5b-9 in inducing inflammatory cell studies establishes that both circulating inflammatory cells and resident glomerular cells can mediate glomerinfiltration by upregulating leukocyte adhesion molecules, or perhaps all of these mechanisms, remains to ular injury acutely by release of oxidants, proteases and probably other chemoattractant and GBMbe established. However, these results indicate that C5b-9 is an important mediator of mesangial immune degrading molecules. Chronic injury is also augmented by release of various cytokines and growth factors that complex diseases such as IgA nephropathy, as well as of diseases of the GEC.
result in increased deposition of extracellular matrix leading to scarring and sclerosis. The following is a (c) Anti-glomerular endothelial cell (GEN ) antibody.The role of antibody and complement in brief summary of recent observations in this area. mediating injury to the GEN is less well studied than in the GEC or mesangial cell. However, antibodies to Neutrophils and platelets [reviewed in 43] GEN have been described in several vasculitic glomer-In any setting where antibodies induce complement ular diseases including IgA nephropathy and SLE [34] , activation or immunoglobulin deposition at sites and complement activation by glomerular immune accessible to circulating inflammatory cells (e.g. subendeposit formation involving exogenous antigens on or dothelial or mesangial immune complex deposits), neubeneath the endothelial cell layer presumably has a trophil infiltration occurs early as a consequence of similar effect. It is likely that sublytic C5b-9 insertion complement-derived and other chemotactic factors into GEN induces production of oxidants and pro- [41] . It has been known since the 1960s that neutrophils teases as has been established with GEC and mesangial cause much of the antibody-induced injury which cells, and may stimulate expression of other molecules follows. Recent studies have substantially clarified how more unique to GEN such as leukocyte adhesion neutrophils localize in glomeruli through interaction molecules, tissue factor and factor VIII. The impor-with a variety of leukocyte adhesion molecules tance of C5b-9 in mediating nephritis in which the (selectins, integrins, ICAM and VCAM ) which are GEN is the principal target has recently been estab-displayed on cell surfaces [42] . Many of these molecules lished by Nangaku et al., who compared a model of are induced or overexpressed in response to cytokines thrombotic microangiopathy induced by antibody to and other inflammatory mediators. It has also been GEN in normal and C-6 deficient PVG rats [35] . They recently established that neutrophils localized in glomfound a marked reduction in fibrinogen deposits, intra-eruli induce injury by undergoing a respiratory burst capillary thrombi, GEN proliferation and macrophage that results in release of toxic oxygen metabolites, infiltration in C-6 deficient animals [36 ] . Thus, C5b-9 particularly H 2 O 2 which is nephritogenic by virtue of is likely an important mechanism of disease involving its ability to interact with neutrophil-derived myelopimmune deposits along the inner surface of the capil-eroxidase (MPO) [44, 45] . MPO is a cationic molecule lary wall as well as in the mesangium and in a which localizes in glomeruli by interacting with negasubepithelial distribution.
tively charged (anionic) sites and reacts with H 2 O 2 and (d) Complement regulatory proteins. With respect a halide to form hypohalous acids that directly damage to glomerular cells, the principal targets of injury in GBM [reviewed in 45] . Even more recently, it has been most forms of glomerulonephritis, these cells are pro-appreciated that in some settings platelets are essential tected from complement attack by several cell-bound for the occurrence of neutrophil mediated injury and complement regulatory proteins including membrane apparently augment this process [46 ] . The nature of co-factor protein (MCP), decay accelerating factor this platelet-neutrophil interaction is still under study. (DAF ) and CD59 [37] . In rodents, Crry serves the Finally, several neutrophil-derived serine proteases complement regulatory function of MCP and DAF including elastase and cathepsin G can also cause and is expressed on all three glomerular cell types. The capillary wall injury and proteinuria in vivo [43, 47] . functional significance of these proteins in complementmediated glomerular disease has been studied by Macrophages Nangaku and colleagues in vitro. Overexpression of both CD59 and Crry by transfected rat mesangial cells Macrophages are also present in the early cellular infiltrate in several different inflammatory glomerular protects these cells from both lytic and sublytic complement attack [38, 39] . Matsuo et al., have demonstrated lesions. Unlike neutrophils, they may localize by immune adherence or in response to cytokines derived that neutralization of Crry with a monoclonal antibody significantly worsens most of the morphological fea-from cell-mediated immune reactions [48, 49] . They effect injury through several mechanisms including tures of mesangioproliferative GN in vivo [40] .
Inflammatory mechanisms of glomerular injury. Most release of oxidants and proteases which directly damage GBM and production of tissue factor which types of GN exhibit striking changes by light microscopy, particularly hypercellularity which may reflect facilitates fibrin deposition and glomerular crescent formation and release of other cytokines and growth infiltration by circulating inflammatory cells such as neutrophils, monocytes or platelets, or proliferation of factors including IL-1 and TGFb which are important stimuli to the production of extracellular matrix by resident glomerular cells, particularly mesangial cells. Examples would include post-infectious GN, IgA glomerular cells [48, 49] .
Mesangial cells
Cell-mediated Immunity [reviewed in 59, 60] Although it has been appreciated since the early 1970s Much attention in recent years has focused on the role that patients with glomerular disease induced by of the mesangial cell in mediation of both immune and nephritogenic autoantibodies often exhibit cellnon-immune types of glomerular injury. Mesangial cell mediated immunity to these antigens as well, the role proliferation is a prominent feature of glomerular of cell-mediated immune mechanisms in causing glomdiseases including IgA nephropathy, lupus nephritis, erular disease has been controversial [61, 62] and some types of steroid resistant nephrotic syndrome difficult to document. However, recent studies clearly and other lesions. Because of the relative ease with demonstrate that specifically sensitized cells, usually which mesangial cells can be grown in vitro, a large utilizing macrophages or perhaps resident glomerular literature has evolved to document the activation of cells as effectors, can induce significant glomerular mesangial cells by a variety of inflammatory mediators injury in the absence of antibody deposition and comincluding C5b-9, certain types of immune complexes, plement activation. Although others have demonendotoxin and various other cytokines and growth strated glomerular structural abnormalities induced by factors. Additional in vitro studies demonstrate that cell-mediated immune mechanisms [63], the most conactivation or proliferation of mesangial cells can lead vincing evidence for the ability of cellular mechanisms to the release of a host of pro-inflammatory materials to cause both structural and functional glomerular including oxidants, proteases, prostaglandins, growth injury derives from the recent studies of Rennke and factors, and extracellular matrix components.
colleagues [64] . These investigators demonstrated that To attempt to define which of these factors identified glomerular localization of an appropriate hapten in in vitro is operative in glomerular disease in vivo, we animals demonstrating cell-mediated immunity to that have employed a model of mesangial proliferative GN hapten resulted in a granulomatous crescentic glominduced by antibody to Thy 1.1 antigen on the mesangerulonephritis without immune deposits which could ial cell membrane (ATS model ). In this model, mesangbe passively transferred using T cells alone [64] . Similar ial cell proliferation is initially associated with a results have been reported by Brouwer et al. using complement-dependent platelet influx and may be MPO (the antigen to which P-ANCA is directed) as mediated in part by the release of bFGF by the antigen [65] . These results are consistent with the mesangial cells undergoing lysis [reviewed in 50-52].
hypothesis that cellular rather than humoral immune Subsequently there is a change in mesangial cell phenomechanisms may be important mediators of some type with expression of a-smooth muscle actin and forms of inflammatory glomerulonephritis in man. increased production of interstitial collagen simulating the properties of myofibroblasts [50] . Proliferating mesangial cells exhibit increased protein and mRNA for PDGF B-chain and PDGF b-receptor, and prolif-Summary eration can be significantly reduced by blocking PDGF suggesting an autocrine mechanism for the mainten-Although glomerular disease remains the most ance of mesangial cell proliferation [53] . Proliferation common cause of end-stage renal disease worldwide, of mesangial cells is probably a process which contrib-major advances have been made recently in underutes to, and augments, glomerular injury. Thus, mes-standing the cellular and molecular mechanisms which angial cell proliferation is associated with increased mediate these disorders. Nephrotic syndrome in nonproduction of mesangial cell derived proteinases that inflammatory lesions such as minimal change/focal localize in areas of basement membrane injury [54] . It sclerosis and membranous nephropathy results from is also associated with increased production of TGFb disorders of the GEC which can be simulated in animal and enhanced gene expression and deposition of models by antibodies to various GEC membrane epinormal mesangial matrix components leading to matrix topes. Clarification of how these antibodies effect the expansion and sclerosis [55] . A similar sequence of GEC to induce a loss of glomerular barrier function altered mesangial cell phenotype and cell proliferation should substantially improve understanding of the preceding upregulation of genes for extracellular pathogenesis of minimal change/focal sclerosis. In MN, matrix component production leading to matrix expan-proteinuria is mediated primarily by C5b-9 through sion and sclerosis has now been documented in non-similar mechanisms that also involve the GEC as a immune models of progressive renal disease as well. target and GEC production of oxidants, proteases and These include the remnant kidney model [56 ] and TGFb in response to sublytic C5b-9 attack. C5b-9 also recently diabetic nephropathy [57] .
mediates mesangial proliferative glomerulonephritis Resolution of glomerular injury involving mesangial induced by anti-mesangial cell antibodies and thromcell proliferation probably involves additional factors botic microangiopathy induced by antibodies to the which regulate and attenuate the mechanisms that glomerular endothelial cell. In all of these lesions drive proliferation. These have not been systematically induced by antibodies to glomerular cells, cell-bound studied at the present time but may include several complement regulatory proteins are important in factors such as TGFb, thrombospondin, SPARC and modulating the injury observed. Upregulation of comnitric oxide, all of which are overproduced in this plement regulatory proteins may prove an effective therapeutic manoeuver in the future. disease and have anti-proliferative effects [58] . 
